Yüklüyor......
Experience with rituximab in the treatment of antineutrophil cytoplasmic antibody associated vasculitis
Prior to the 1970s, severe cases of antineutrophil cytoplasmic antibody associated vasculitis (AAV) were thought to be invariably fatal. However, the use of cyclophosphamide-based treatment regimens fundamentally altered disease outcomes, transforming AAV into a manageable, chronic illness. Despite...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
SAGE Publications
2014
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3956138/ https://ncbi.nlm.nih.gov/pubmed/24688606 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1759720X13516239 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|